Improved absorption of cyclosporine for microemulsion in a pediatric liver transplant recipient with cystic fibrosis

Transplantation

Volumn 61, Issue 2, 1996, Pages 331-333

  Pescovitz, Mark D ^a   Puente, Jorge G ^b   Jindal, Rahul M ^a   Fitzgerald, Joseph ^c   Chong, Sonny K F ^c   Milgrom, Martin L ^a   Leapman, Stephen B ^a   Filo, Ronald S ^a  

^a INDIANA UNIVERSITY   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c Sandoz Pharma Ltd   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A;

ADOLESCENT; ARTICLE; BILE SECRETION; CASE REPORT; CYSTIC FIBROSIS; DRUG ABSORPTION; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; LUNG FUNCTION; MALE; PANCREAS FUNCTION; PANCREAS SECRETION; PRIORITY JOURNAL; RECIPIENT;

CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; CYSTIC FIBROSIS; DRUG DELIVERY SYSTEMS; EMULSIONS; GRAFT REJECTION; HUMANS; LIVER TRANSPLANTATION;

EID: 0030021020     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199601270-00030     Document Type: Article

References (20)

1. Revell SP, Noble-Jamieson G, Roberton NRC, Barnes ND. Liver transplantation in cystic fibrosis. Royal Soc Med 1993; 86: 111.
2. Mieles LA, Orenstein D, Teperman L, Podesta L, Koneru B, Starzl TE. Liver transplantation in cystic fibrosis. Lancet 1989; 1: 1073.
3. Noble-Jamieson G, Valente J, Barnes ND, et al. Liver transplantation for hepatic cirrhosis in cystic fibrosis. Arch Dis Childhood 1994; 71: 349.
4. Williams SGJ, Westaby D, Tanner MS, Mowat AP. Liver and biliary problems in cystic fibrosis. Br Med Bull 1992; 48: 877.
5. Mehta MU, Venkataramanan R, Burckart GJ, et al. Effect of bile on cyclosporin absorption in liver transplant patients. Br J Clin Pharmac 1988; 25: 579.
6. Vonderscher J, Meinzer A. Rationale for the development of Sandimmune Neoral. Transplant Proc 1994; 26: 2925.
7. Kahan BD, Dunn J, Fitts C, et al. Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low fat or high fat meals. Transplantation 1995; 59: 505.
8. Kahan BD, Dunn J, Fitts C, et al. The Neoral formulation: improved correlation between cyclosporine trough levels and exposure in stable renal transplant recipients. Transplant Proc 1994; 26: 2940.
9. Sketris IS, Lawen JG, Beauregard-Zollinger L, et al. Comparison of the pharmacokinetics of cyclosporine Sandimmune with Sandimmune Neoral in stable renal transplant patients. Transplant Proc 1994; 26: 2961.
10. Mehta PL, Alaka KJ, Filo RS, Leapman SB, Milgrom ML, Pescovitz MD. Nutrition support following liver transplantation: comparison of jejunal versus parenteral routes. Clin Transplant 1995; 9: 364.
11. Pescovitz MD, Mehta PL, Leapman SB, Milgrom ML, Jindal RM, Filo RS. Tube jejunostomy in liver transplant recipients. Surgery 1995; 117: 642.
12. Pescovitz MD, Book BK, Pollard SG, Milgrom ML, Leapman SB, Filo RS. An evaluation of the cyclosporine parent-compound-specific whole blood TDx assay. Clin Transplant 1992; 6: 43.
13. Burckart G, Starzl T, Williams L, et al. Cyclosporine monitoring and pharmacokinetics in pediatric liver transplant patients. Transplant Proc 1985; 17: 1172.
14. Whitington PF, Emond JC, Whitington SH, Broelsch CE, Baker AL. Small-bowel length and the dose of cyclosporine in children after liver transplantation. N Engl J Med 1990; 322: 733.
15. Lin CY, Lee SF. Comparison of pharmacokinetics between CsA capsules and Sandimmune Neoral in pediatric patients. Transplant Proc 1994; 26: 2973.
16. Sokol RJ, Johnson KE, Karrer FM, Narkewicz MR, Smith D, Kam I. Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E. Lancet 1991; 338: 212.
17. Johnston A, Sketris I, Marsden JT, et al. A limited sampling strategy for the measurement of cyclosporine AUC. Transplant Proc 1990; 22: 1345.
18. Keown PA, Stiller CR, Laupacis AL, et al. The effects and side effects of cyclosporine: relationship to drug pharmacokinetics. Transplant Proc 1982; 14: 659.
19. Foley RJ, Van Buren CT, Hammer R, Weinmann EJ. Cyclosporine-associated hyperkalemia. Transplant Proc 1983; 15: 2726.
20. Lindholm A, Kahan B. Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 1993; 54: 205.